ConductScience.org, home

Paper589672

On the varied biologic effects of interferon.

Gresser I. Cell Immunol, 1977. Cited by 371 papers, by iCite.

Cite this record

ConductScience Library. On the varied biologic effects of interferon. Papers, record 589672. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/589672

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
On the varied biologic effects of interferon.
PubMed
Journal
Cell Immunol
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
371
iCite
Relative citation ratio, by iCite
10.5
iCite
Revised in PubMed
2019-07-20
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gresser II

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
InterferonsMajor topic
Antibody Formation
Cell Division
Cell Membrane

Cited by54

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 371 citations.

PMIDTitleJournalYearIn PapersSource
34734110Engineering Strategies for Immunomodulatory Cytokine Therapies - Challenges and Clinical Progress.Adv Ther (Weinh)2021https://conductscience.org/library/papers/34734110PubMed
12498390Evidence for the causal role of endogenous interferon-alpha/beta in the regulation of angiogenesis, tumorigenicity, and metastasis of cutaneous neoplasms.Clin Exp Metastasis2002https://conductscience.org/library/papers/12498390PubMed
8205559A phase II study of combined administration of dacarbazine and carboplatin with home therapy of recombinant interleukin-2 and interferon-alpha 2a in patients with advanced malignant melanoma.Cancer Immunol Immunother1994https://conductscience.org/library/papers/8205559PubMed
7276828In vitro generation of human cytotoxic lymphocytes by virus. Viral glycoproteins induce nonspecific cell-mediated cytotoxicity without release of interferon.J Exp Med1981https://conductscience.org/library/papers/7276828PubMed
6865941Growth regulation of melanoma cells by interferon and (2'-5')oligoadenylate synthetase.Mol Cell Biol1983https://conductscience.org/library/papers/6865941PubMed
6678308Interferon effects on multiplication, cytoplasmic protein and GFAP content, and morphology in human glioma cells.J Neurooncol1983https://conductscience.org/library/papers/6678308PubMed
6620465Blockage of antiviral induction of interferon by homologous cell biochemical activity: effect of chicken embryo fibroblast mitotic cell cycle phases on Sindbis virus growth.J Virol1983https://conductscience.org/library/papers/6620465PubMed
6611523Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.Neurosurg Rev1984https://conductscience.org/library/papers/6611523PubMed
6444662Interferon as a mediator of human lymphocyte suppression.J Exp Med1980https://conductscience.org/library/papers/6444662PubMed
6384555Porcine leukocyte cellular subsets sensitive to African swine fever virus in vitro.J Virol1984https://conductscience.org/library/papers/6384555PubMed
6371020Interferon suppresses pinocytosis but stimulates phagocytosis in mouse peritoneal macrophages: related changes in cytoskeletal organization.J Cell Biol1984https://conductscience.org/library/papers/6371020PubMed
6243926Antagonism in action between mouse or human interferon and platelet growth factor.Arch Virol1980https://conductscience.org/library/papers/6243926PubMed
6198116Target-effector interactions in the rat NK cell system. II. Effects of interferon on lytic efficiency and on pre-NK cells in various organs, rat strains and during ontogeny.Clin Exp Immunol1984https://conductscience.org/library/papers/6198116PubMed
6195717Interferon and reversion of the transformed phenotype.Surv Immunol Res1982https://conductscience.org/library/papers/6195717PubMed
6192149Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.J Clin Invest1983https://conductscience.org/library/papers/6192149PubMed
6187920Interferon therapy and immunity.J R Soc Med1983https://conductscience.org/library/papers/6187920PubMed
6181288Interferons and bacterial infections.Klin Wochenschr1982https://conductscience.org/library/papers/6181288PubMed
6178542Insensitivity to interferon of NK cells from patients with systemic lupus erythematosus.Clin Exp Immunol1982https://conductscience.org/library/papers/6178542PubMed
6178224Advances in interferon research - Medical Staff Conference.West J Med1982https://conductscience.org/library/papers/6178224PubMed
6175574Susceptibility of bovine macrophages to infectious bovine rhinotracheitis virus infection.Infect Immun1982https://conductscience.org/library/papers/6175574PubMed

See all 54 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/589672

GET https://conductscience.org/api/papers/v1/589672/cited_by?page=2